RDNT

$73.18+0.11%

RadNet, Inc.

Market Cap

$5.8B

Live price × SEC shares (Aug 6, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

1.42

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

2.5

TTM to Jun 2026 · revenue

P/B

5.3

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

26.3

TTM to Jun 2026 · EV incl. net debt

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	522,869	547,712	575,631	622,720	2,268,932
Total operating expenses	495,480	519,887	599,534	583,252	2,198,153
Operating income	27,389	27,825	(23,903)	39,468	70,779
Interest expense	17,355	18,130	17,657	18,153	71,295
Pretax income	20,274	20,916	(32,828)	26,617	34,979
Income tax	6,385	11,055	(8,096)	6,363	15,707
Net income	5,417	(597)	(33,466)	7,530	(21,116)
EPS (basic) ($)	0.07		(0.43)	0.10	(0.26)
EPS (diluted) ($)	0.07		(0.43)	0.10	(0.26)
Weighted avg. shares (basic)	75,950		77,058	77,788
Weighted avg. shares (diluted)	77,388		77,058	78,731

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 10, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

13 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 26, 2026 accepted 4:11 PM ET	1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure	Document SEC ↗
Aug 14, 2026 accepted 4:17 PM ET	8.01Other events	Document SEC ↗
Aug 10, 2026 accepted 6:07 AM ET	2.02Earnings release	Document SEC ↗
Jun 10, 2026 accepted 5:23 PM ET	1.01Material agreement2.03New debt obligation7.01Reg FD disclosure	Document SEC ↗
Jun 4, 2026 accepted 9:08 PM ET	5.07Shareholder vote	Document SEC ↗
Jun 3, 2026 accepted 8:07 AM ET	8.01Other events	Document SEC ↗
May 11, 2026 accepted 7:24 AM ET	2.02Earnings release	Document SEC ↗
Mar 2, 2026 accepted 7:01 AM ET	2.02Earnings release	Document SEC ↗
Mar 2, 2026 accepted 7:00 AM ET	7.01Reg FD disclosure	Document SEC ↗
Jan 30, 2026 accepted 4:17 PM ET	8.01Other events	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

63%

W/W +0.0pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-06-18	2026-06-22	SWARTZ DAVID L	Director	Sale	2,699	$53.89	$145K	177.0K	View
2026-06-16	2026-06-18	Wesdorp Cornelis	Pres & CEO, Digital Health	Sale	4,750	$58.11	$276K	69.1K	View
2026-06-15	2026-06-16	Forthuber Stephen M	Pres & CEO-Eastern Operations	Sale	44.1K	$58.16	$2.56M	507.2K	View
2026-03-19	2026-03-23	Sorensen Alma Gregory	Director & Chief Strategy Officer	Sale	15.0K	$62.20	$933K	1.21M	View
2026-03-18	2026-03-18	Sorensen Alma Gregory	Director & Chief Strategy Officer	Sale	15.0K	$62.15	$932K	1.22M	View